 |
|
|
| |
A Phase 2 Study of BMS-986036 (PegylatedFGF21) in Obese Adults with Type 2 Diabetes and a High Prevalence of Fatty Liver
|
| |
| |
Reported by Jules Levin
The Liver Meeting, American Association for the Study of Liver Diseases (AASLD 2016)Boston, Massachusetts, November 11-15, 2016
Edgar D. Charles,1Brent A. Neuschwander-Tetri,2Yi Luo,1
ChunyuKate Wu,1Rose Christian1
1Bristol-Myers Squibb, Lawrenceville, NJ; 2Saint Louis University, St. Louis, MO
|
| |
|
|
|
|
|
